NEW
YORK, March 3, 2025 /PRNewswire/ -- Today's
Marketplace (TMP) is proud to announce a featured interview with
Ensysce Biosciences (NASDAQ: ENSC) CEO Dr. Lynn Kirkpatrick and Dr. Neel Pathak, DS,
Program Director with Creighton
University. The doctors joined TMP's host Jane King to discuss the ongoing issues with
opioids for pain management and how "clever chemistry" is being
used to introduce safer opioids that are less prone to accidental
overdose and abuse.
"Our team uses what I like to call 'clever
chemistry' to create the next generation of opioids."
The full interview can be viewed online here.
"[Unfortunately,] opioids are still being prescribed for pain
because, for many patients, there still are no other alternatives
available to meet their needs for relief of severe and chronic
pain, such as post-acute surgical care, cancer care, palliative
care, etc. Yet we all know that opioids come with severe risks as
well. Still, there are about 3 million patients a year that have no
choice but to rely on opioids."
Dr. Pathak went on to explain to King that those risks not only
encompass health concerns like abuse and addiction but also have a
serious economic impact, costing the healthcare industry almost
one trillion dollars annually!
Dr. Kirkpatrick explained how Ensysce Biosciences is trying to
change all that by introducing safer opioids.
"Our team uses what I like to call 'clever chemistry' to create
the next generation of opioids," she told King. "The clever
chemistry is designed to not only reduce abuse but to make these
products safer, so patients in pain can have less fear and higher
confidence level in taking opioid medications when they need
them."
The pharmaceutical industry recognizes the opioid crisis in
America. Whereas other companies have invested billions of dollars
unsuccessfully trying to develop other forms of painkillers that
are as effective as opioids, Dr. Kirkpatrick said her company has
taken a different approach -- which is to re-engineer opioids so
that doctors can be confident prescribing and patients more
comfortable taking.
Dr. Kirkpatrick further clarifies, "[To date] there are no
products on the market that can surpass the pain relief of opioids.
We are chemically modifying opioids, making them inactive unless
they are taken orally, which significantly cuts down the chances of
abuse."
That "clever" chemical engineering also includes built-in
safeguards against overdose that prevent the medication from being
released if more than the prescribed dosage is ingested. All of
this while still making the drug – in this case, oxycodone – still
effective as always in alleviating pain.
"This is great because now we have a biological way to prevent
abuse and increase patient confidence," says Dr. Pathak.
Kirkpatrick said that their chemically modified oxycodone has
received FDA "Fast Track" as well as "Breakthrough Therapy"
designation, which means the agency recognizes the "medical need"
for this kind of product as well as the improvement over available
therapies and is doing its best to expedite its availability to the
public.
TMP's interviews cover important business topics and solutions
with insights from academic experts and business leaders. Dr.
Kirkpatrick said her appearance on TMP was a great way to get her
company's vision across to a national audience. "TMP provides a
perfect platform to be able to discuss the dueling crises in
America today, the needs of millions of Americans for opioid pain
treatment to function daily versus the regulations that have been
put in place to restrict opioid use. Ensysce is pleased that their
approach may be able to break this impasse."
About Ensysce Biosciences
Ensysce is a developer of first-in-class, uniquely innovative
solutions in oral drug delivery. Their proprietary TAAP™ and
MPAR® technologies improve the care and safety of
patients by preventing the possibility of both abuse and overdose
of prescription drugs. Learn more by visiting ensysce.com.
About Creighton
University
Creighton University is a Jesuit,
Catholic university located in Omaha,
Neb., that enrolls more than 4,100 undergraduate and 3,200
professional school and graduate students bridging health, law,
business, and the arts and sciences for a more just world. For more
information, visit our website at: www.creighton.edu.
About Today's Marketplace
Today's Marketplace (TMP) is a series of C-Suite interviews
filmed at the prestigious New York Stock Exchange (NYSE) and the
NASDAQ MarketSite studio for earned media distribution. TMP's
multi-channel distribution provides robust authoritative and
credible media exposure to under-reported stories. Visit TMP at
todaysmarketplace.tv
Media Contact:
Diane Rygh;
producers@cmghd.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ensysce-biosciences-ceo-dr-lynn-kirkpatrick-and-creighton-universitys-dr-neel-pathak-discuss-the-opioid-crisis-and-next-generation-opioids-302390154.html
SOURCE Today's Marketplace
